Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
544
Total Claims
$1.8M
Drug Cost
77
Beneficiaries
$23K
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+627%
Opioid rate vs peers
45.6% vs 6.3% avg
+70%
Cost per patient vs peers
$23K vs $14K avg
+93%
Brand preference vs peers
28.1% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 627% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
45.6%
Opioid Rate
248
Opioid Claims
$8,354
Opioid Cost
10.5%
Long-Acting Rate
This provider's opioid prescribing rate of 45.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 153 claims · $1.6M
Generic: 391 claims · $209K
Patient Profile
44
Avg Age
69%
Female
5.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About